A real world observational study to determine trends in patient characteristics, overall survival and time to treatment failure in metastatic pancreatic adenocarcinoma patients treated with liposomal Irinotecan based regimens
Latest Information Update: 11 Jun 2020
At a glance
- Drugs Irinotecan (Primary)
- Indications Adenocarcinoma; Pancreatic cancer
- Focus Therapeutic Use
Most Recent Events
- 11 Jun 2020 New trial record
- 31 May 2020 Results presented at the 56th Annual Meeting of the American Society of Clinical Oncology